This study will investigate the effects of psilocybin dose and the frequency and intensity of support activities for spiritual practice (e.g., meditation) on a battery of attitudinal and behavioral outcome measures in 75 healthy volunteers who are interested in pursuing a program of spiritual practices with the intention applying spiritual insights and knowledge to everyday life.
Topic Healthy Subjects
Compound Placebo
Psilocybin
Country United States of America
Visit trial
Trial Details
Trial Number
Sponsors & Collaborators
Johns Hopkins UniversityJohns Hopkins University (Medicine) is host to the Center for Psychedelic and Consciousness Research, which is one of the leading research institutes into psychedelics. The center is led by Roland Griffiths and Matthew Johnson.
The CSP Fund of the San Francisco Foundation
This company doesn't have a full profile yet, it is linked to a clinical trial.
Fetzer Institute
This company doesn't have a full profile yet, it is linked to a clinical trial.
Papers
Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviorsThis double-blind, placebo-controlled study (n=75) found that two high dosages (20 & 30mg/70kg) of psilocybin in combination with spiritual practice showed significant positive (and enduring) effects over that of spiritual practice alone. This effect was even more pronounced on various measures when more support (high support) was given to those on the high (non-placebo) dose.
Measures Used
States of Consciousness QuestionnaireThe States of Consciousness Questionnaire (SOCQ) was developed to assess the occurrence features of the change in consciousness induced by psilocybin and includes the Mystical Experience Questionnaire (MEQ). The SOCQ consists of 100 items, 43 of which are from the MEQ.